Effect of Triamcinolone and Jelfum in reducing the symptoms of allergic rhinitis

Phase 1

Recruiting

• Conditions: Allergic Rhinitis.; Other allergic rhinitis; J30.8

• Registration Number: IRCT20210915052490N1
• Lead Sponsor: Kermanshah University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 November 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

ARIA Criteria Diagnosis of allergic rhinitis

Exclusion Criteria

History of rhinoplasty
Anatomical disorders of the nose
Persistent asthma
Prolonged use of corticosteroids
Tuberculosis
Diabetes
Chronic systemic diseases
Pregnancy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sneezing. Timepoint: At the beginning of the study (before the intervention) and 7, 14, 21 and 28 days after the intervention. Method of measurement: Based on question from the person (The rate of patient sneezing based on the number of episodes of the patient's daily sneezing).;Runny nose. Timepoint: At the beginning of the study (before the intervention) and 7, 14, 21 and 28 days after the intervention. Method of measurement: Based on a question from the person (number of sheets of tissue paper consumed by the patient per day).;Nasal congestion. Timepoint: At the beginning of the study (before the intervention) and 7, 14, 21 and 28 days after the intervention. Method of measurement: Based on the scores that patient gives to these symptoms from zero to three.;Itchy nose. Timepoint: At the beginning of the study (before the intervention) and 7, 14, 21 and 28 days after the intervention. Method of measurement: Based on the scores that patient gives to these symptoms from zero to three.